Literature DB >> 18432546

Ocular toxicity of hydroxychloroquine.

Rodney Tehrani1, Rochella A Ostrowski, Richard Hariman, Walter M Jay.   

Abstract

This review summarizes the current literature regarding the ocular complications of hydroxychloroquine. Hydroxychloroquine has been used since the 1950s for the treatment of various rheumatic and dermatologic diseases. Hydroxychloroquine can cause ocular toxicity, with the most serious being an irreversible retinopathy. At the present time, no "gold standard" exists for identification of the ocular toxicity prior to its development. This has led to controversy regarding the recommendations for ophthalmologic examinations for screening patients on hydroxychloroquine.

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18432546     DOI： 10.1080/08820530802049962

Source DB:  PubMed          Journal:  Semin Ophthalmol        ISSN： 0882-0538            Impact factor:   1.975


  29 in total

1.  Optical Coherence Tomography Minimum Intensity as an Objective Measure for the Detection of Hydroxychloroquine Toxicity.

Authors:  Ali M Allahdina; Paul F Stetson; Susan Vitale; Wai T Wong; Emily Y Chew; Fredrick L Ferris; Paul A Sieving; Catherine Cukras
Journal:  Invest Ophthalmol Vis Sci       Date:  2018-04-01       Impact factor: 4.799

Review 2.  Antimicrobial therapies for Q fever.

Authors:  Gilbert J Kersh
Journal:  Expert Rev Anti Infect Ther       Date:  2013-09-27       Impact factor: 5.091

3.  Lucanthone is a novel inhibitor of autophagy that induces cathepsin D-mediated apoptosis.

Authors:  Jennifer S Carew; Claudia M Espitia; Juan A Esquivel; Devalingam Mahalingam; Kevin R Kelly; Guru Reddy; Francis J Giles; Steffan T Nawrocki
Journal:  J Biol Chem       Date:  2010-12-10       Impact factor: 5.157

Review 4.  A Critical Review of the Effects of Hydroxychloroquine and Chloroquine on the Eye.

Authors:  Nathalie Costedoat-Chalumeau; Bertrand Dunogué; Gaëlle Leroux; Nathalie Morel; Moez Jallouli; Véronique Le Guern; Jean-Charles Piette; Antoine P Brézin; Ronald B Melles; Michael F Marmor
Journal:  Clin Rev Allergy Immunol       Date:  2015-12       Impact factor: 8.667

Review 5.  Systemic lupus erythematosus and ocular involvement: an overview.

Authors:  Rosanna Dammacco
Journal:  Clin Exp Med       Date:  2017-12-14       Impact factor: 3.984

6.  Reversible binocular visual loss in temporal association with artesunate-amodiaquine treatment in a child on mefloquine chemoprophylaxis.

Authors:  G O Adjei; V M Adabayeri; S H Annobil
Journal:  Ghana Med J       Date:  2012-09

7.  Using zinc ion-enhanced fluorescence of sulfur quantum dots to improve the detection of the zinc(II)-binding antifungal drug clioquinol.

Authors:  Jie Zhao; Zhefeng Fan
Journal:  Mikrochim Acta       Date:  2019-12-03       Impact factor: 5.833

8.  Regular examinations for toxic maculopathy in long-term chloroquine or hydroxychloroquine users.

Authors:  Melisa Nika; Taylor S Blachley; Paul Edwards; Paul P Lee; Joshua D Stein
Journal:  JAMA Ophthalmol       Date:  2014-10       Impact factor: 7.389

9.  Should Acute Q-Fever Patients be Screened for Valvulopathy to Prevent Endocarditis?

Authors:  Marit M A de Lange; Laura E V Gijsen; Cornelia C H Wielders; Wim van der Hoek; Arko Scheepmaker; Peter M Schneeberger
Journal:  Clin Infect Dis       Date:  2018-07-18       Impact factor: 9.079

10.  A New Objective Parameter in Hydroxychloroquine-Induced Retinal Toxicity Screening Test: Macular Retinal Ganglion Cell-Inner Plexiform Layer Thickness.

Authors:  Mehmet Bulut; Muhammet Kazım Erol; Devrim Toslak; Melih Akidan; Ebru Kaya Başar; Hasan Fatih Çay
Journal:  Arch Rheumatol       Date:  2017-10-16       Impact factor: 1.472
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.